Intellia Therapeutics Inc (NTLA)
EBITDA Margin
-1365.09%
Quarterly · Period ending:
NTLA EBITDA Margin
Latest reported-1365.09%period ending
Latest reported-1365.09%period ending
NTLA Quarterly EBITDA Margin (0.00% → -1365.09%)
Quarterly ebitda margin
High-resolution chart · PNG
NTLA ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -1,365.0868% | |
| -624.8604% | |
| -414.5154% | |
| -699.376% | |
| -693.4433% | |
| -672.5868% | |
| -981.2956% | |
| -1,460.9154% | |
| -2,075.2623% | |
| -362.6197% | |
| 6,765.519% | |
| -1,000.1167% | |
| -893.8576% | |
| -801.8087% | |
| -820.5702% | |
| -838.8286% | |
| -704.4975% | |
| -1,289.7085% | |
| -617.372% | |
| -969.7113% | |
| -1,025.5267% | |
| -695.64% | |
| -618.605% | |
| -119.2619% | |
| -193.4944% | |
| -243.9378% | |
| -257.7542% | |
| -225.5558% | |
| -234.9523% | |
| -215.7481% | |
| -247.703% | |
| -309.7597% | |
| -293.3698% | |
| -286.7586% | |
| -358.1584% | |
| -206.1637% | |
| -258.6784% | |
| -197.7152% | |
| -185.1253% | |
| -152.6391% | |
| -159.2725% | |
| -366.179% | |
| -316.5387% | |
| -189.8697% | |
| -243.6456% | |
| -90.3577% | |
| 0% | |
| 0% |